Search Page

1

Cite

Share

Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.

Schneeweiss S, Gopalakrishnan C, Bartels DB, Franklin JM, Zint K, Kulldorff M, Huybrechts KF. Schneeweiss S, et al. Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005173. doi: 10.1161/CIRCOUTCOMES.118.005173. Circ Cardiovasc Qual Outcomes. 2019. PMID: 30764655

Cite

Share

2

Cite

Share

Saxagliptin protects against hypoxia-induced damage in H9c2 cells.

Zhang L, Qi X, Zhang G, Zhang Y, Tian J. Zhang L, et al. Chem Biol Interact. 2020 Jan 5;315:108864. doi: 10.1016/j.cbi.2019.108864. Epub 2019 Oct 17. Chem Biol Interact. 2020. PMID: 31629700

Cite

Share

3

Cite

Share

Extension of Disease Risk Score-Based Confounding Adjustments for Multiple Outcomes of Interest: An Empirical Evaluation.

Desai RJ, Wyss R, Jin Y, Bohn J, Toh S, Cosgrove A, Kennedy A, Kim J, Kim C, Ouellet-Hellstrom R, Karami S, Major JM, Niman A, Wang SV, Gagne JJ. Desai RJ, et al. Am J Epidemiol. 2018 Nov 1;187(11):2439-2448. doi: 10.1093/aje/kwy130. Am J Epidemiol. 2018. PMID: 29947726

Cite

Share

4

Cite

Share

Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients.

Yang CY, Lin WA, Su PF, Li LJ, Yang CT, Ou HT, Kuo S. Yang CY, et al. Clin Pharmacol Ther. 2021 Mar;109(3):772-781. doi: 10.1002/cpt.2058. Epub 2020 Oct 16. Clin Pharmacol Ther. 2021. PMID: 32978779 Free article.

Cite

Share

5

Cite

Share

Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database.

Saunders-Hastings P, Heong SW, Srichaikul J, Wong HL, Shoaibi A, Chada K, Burrell TA, Dores GM. Saunders-Hastings P, et al. PLoS One. 2021 Jul 1;16(7):e0253580. doi: 10.1371/journal.pone.0253580. eCollection 2021. PLoS One. 2021. PMID: 34197488 Free PMC article.

Cite

Share

6

Cite

Share

Conducting prospective sequential surveillance in real-world dynamic distributed databases.

Maro JC, Eworuke E, Hou L, Welch EC, Goulding MR, Izem R, Lee JY, Toh S, Fireman B, Nguyen MD. Maro JC, et al. Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1331-1335. doi: 10.1002/pds.5002. Epub 2020 May 25. Pharmacoepidemiol Drug Saf. 2020. PMID: 32449261 No abstract available.

Cite

Share

7

Cite

Share

Targeting AGE-RAGE signaling pathway by Saxagliptin prevents myocardial injury in isoproterenol challenged diabetic rats.

Kumar R, Bhargava P, Suchal K, Bhatia J, Arya DS. Kumar R, et al. Drug Dev Res. 2021 Jun;82(4):589-597. doi: 10.1002/ddr.21779. Epub 2021 Jan 17. Drug Dev Res. 2021. PMID: 33458850

Cite

Share

8

Cite

Share

Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?

Suissa S, Israel E, Donohue J, Evans S, Kemp J. Suissa S, et al. Am J Respir Crit Care Med. 2018 Apr 15;197(8):987-990. doi: 10.1164/rccm.201709-1940PP. Am J Respir Crit Care Med. 2018. PMID: 29357261 No abstract available.

Cite

Share

9

Cite

Share

Assessing the impact of the new ICD-10-CM coding system on pharmacoepidemiologic studies-An application to the known association between angiotensin-converting enzyme inhibitors and angioedema.

Panozzo CA, Welch EC, Woodworth TS, Huang TY, Her QL, Gagne JJ, Sun JW, Rogers C, Menzin TJ, Ehrmann M, Freitas KE, Haug NR, Toh S. Panozzo CA, et al. Pharmacoepidemiol Drug Saf. 2018 Aug;27(8):829-838. doi: 10.1002/pds.4550. Epub 2018 Jun 26. Pharmacoepidemiol Drug Saf. 2018. PMID: 29947045

Cite

Share

10

Cite

Share

The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes.

Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA. Stoian AP, et al. Metabolism. 2020 Aug;109:154295. doi: 10.1016/j.metabol.2020.154295. Epub 2020 Jun 15. Metabolism. 2020. PMID: 32553739 Review.

Cite

Share